Skip to main content

01.12.2018 | Letter | Ausgabe 1/2018 Open Access

Critical Care 1/2018

Can nutritional interventions change major clinical outcomes?

Critical Care > Ausgabe 1/2018
Sho Horikita, Masamitsu Sanui, Alan K. Lefor
Enteral nutrition
Parenteral nutrition
Randomized controlled trial
In the NUTRIREA-2 trial [ 1] recently published in the Lancet, the authors assessed whether early enteral nutrition (EN) decreases mortality compared with early parenteral nutrition (PN) in patients undergoing invasive mechanical ventilation and vasopressor support for shock, with normo-caloric targets for both routes of support. As the primary endpoint, mortality on day 28 was comparable between the groups. However, we believe that nutritional protocols for both study groups deviated from current standards of nutritional therapy for critically ill patients, which makes interpretation of the results difficult.
There are no clear data showing that EN targeting full caloric requirements immediately after admission is superior to permissive hypocaloric EN [ 2, 3]. Recent large randomized controlled trials (RCTs) even suggest that full caloric EN has some disadvantages over hypocaloric EN, including gastrointestinal intolerance [ 2]. The latest Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition guidelines [ 4] suggest that EN is the preferred nutritional route for the majority of critically ill patients. Therefore, there is no clear justification for patients in refractory shock to receive full-caloric EN as in the NUTRIREA-2 trial [ 1], although these unstable patients may tolerate trophic feeding or underfeeding. In the real world, critical care staff would take significant advantage of less gastrointestinal complications along with non-inferiority of hypocaloric to normocaloric EN.
Also, there are no definite data showing that early PN beginning within a few days of ICU admission, either supplemental or exclusive PN to meet full-caloric goals, has a significant clinical benefit. In the EPaNIC trial [ 5], early PN supplementation to hypocaloric EN for full caloric targets did not improve mortality in critically ill patients, but did increase the rate of infections. Therefore, full-caloric PN is not the current standard nutritional therapy for critically ill patients.
For unstable patients requiring vasopressors and mechanical ventilation, we believe that trophic EN is the first-line nutritional therapy. Based on the fact that none of the EN or PN nutritional protocols [ 13, 5] showed a benefit of nutritional therapy on clinically important outcomes in critically ill patients, additional efforts to investigate a particular nutritional therapy to improve clinical outcomes during the acute phase may not be advocated. It is rather reasonable to investigate a nutritional therapy to do the least harm. We need to appreciate the idea that nutrition does not give strength to patients, but can potentially do harm to patients.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2018

Critical Care 1/2018 Zur Ausgabe

Neu im Fachgebiet AINS

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update AINS und bleiben Sie gut informiert – ganz bequem per eMail.